MOUNTAIN VIEW, Calif., Nov. 10, 2010 (GLOBE NEWSWIRE) -- Conceptus, Inc. (Nasdaq:CPTS), developer of the Essure® procedure, the most effective non-surgical permanent birth control method available, today announced it will begin promoting GYNECARE THERMACHOICE®(1) Uterine Balloon Therapy System in U.S. OB/GYN physician offices. GYNECARE THERMACHOICE® is a global endometrial ablation product that is used to treat excessive uterine bleeding (menorrhagia). The product is manufactured for and marketed by ETHICON™ Women's Health & Urology, a division of Ethicon, Inc.
